1. Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells
   Mengmeng Yang et al, 2021, J Cancer Res Clin Oncol CrossRef
2. Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis
   Ioannis A. Vathiotis et al, 2021, IJMS CrossRef
3. Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer
   Yinghao Zhao et al, 2023, Front. Oncol. CrossRef
4. The application of Interleukin-2 family cytokines in tumor immunotherapy research
   Yangyihua Zhou et al, 2023, Front. Immunol. CrossRef
5. A deep learning approach based on multi-omics data integration to construct a risk stratification prediction model for skin cutaneous melanoma
   Weijia Li et al, 2023, J Cancer Res Clin Oncol CrossRef
6. Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance
   Maliheh Entezari et al, 2024, CCDT CrossRef
7. Therapeutic potential of interleukin-21 in cancer
   Gheorghita Isvoranu et al, 2024, Front. Immunol. CrossRef
8. IL21R hypomethylation as a biomarker for distinguishing benign and malignant breast tumours
   Zishan Zang et al, 2024, Epigenetics CrossRef
9. Study on the effect and mechanisms of piperine against cervical cancer based on network pharmacology and experimental validation
   Hui Cheng et al, 2023, Biotechnology and Genetic Engineering Reviews CrossRef
10. IL-21 and IL-33 May Be Effective Biomarkers to Predict the Efficacy of PD-1 Monoclonal Antibody for Advanced Cholangiocarcinoma
    Haijiao Yan et al, 2025, Cancer Biotherapy and Radiopharmaceuticals CrossRef